Medicinal Chemistry
   Hit ID/Hit-2-Lead
   Lead ID
   Preclinical Efficacy
   In Vivo Disease Models
   Transgenic Services
   Biomarker Services
   Biologics Discovery
   Nature Product Library
   Peptides
   Other Products
Print E-mail Contact us
News & Events
HD Biosciences Ranks in ¡°2011 Deloitte Technology Fast 50 China¡±
HD Biosciences Announces the Appointment of Dr. Maosheng Duan as Vice President and Head of Medicinal Chemistry.
HD Biosciences Launches Medicinal Chemistry for SAR Focused R&D Services.
HD Biosciences Co. LTD Received AAALAC Accreditation on Its Animal Facility.
Histone deacetylase inhibitor screening platform established at HDB.
HDB gains international recognition for its in vivo pharmacology in behavioral research area.
HDB animal facility has received approval from an unnamed global pharmaceutical company for its in vivo research.
A high throughput CYP450 cocktail IC50 assay has been developed recently by the DMPK and Analytical team of HDB.
HD Biosciences partners with Discoverx Corp. to Provide Services With Innovative Technology Platforms.
Pfizer awarded HDB¡¯s scientific leader "Different Marker" for her great contribution in one of the research collaborations.
HDB granted ¡°fast track custom clearance¡± green channel privilege in Zhang Jiang Shanghai.
CellCentric Expands Drug Screening Collaborations with HDB in Shanghai.
HDB Announces the Appointment of Several Positions in DMPK. Bioanalytical Service and in vitro Toxicology.
HD Biosciences Moved to the Zhangjiang East Campus.
HD Biosciences Co., Ltd. (HDB) was awarded ¡°2008 Top Research Service Partner Award¡± by Pfizer Inc in recognition of quality, productivity, and value that HD Biosciences brought to Pfizer over the past year.
HD Biosciences Adds New Tools to Enhance Assay and Screening Facilities.
HD Biosciences successfully launched Wash Free Fluo-8 Calcium Assay Kits to the market. Good news for researchers around the world that Wash free Fluo-8 Calcium Assay kit with much higher signal intensity and assay robustness is now available.
Oct. 2, 2008 - HD Biosciences Announces a grand renovation plan to its newly leased facility in Zhangjiang Hi-Tech Park (East).
HD Biosciences Announces the Appointment of Senior Vice President of Discovery Biology. Sept. 8, 2008 - HD Biosciences Inc. (HDB) announces the hiring of Dr. Peiyuan Lin as Senior Vice President of Discovery Biology.
HD Biosciences Announces the Appointment of Head of Business Development and Project Development. Sept. 8, 2008 - HD Biosciences Inc. (HDB) announces the hiring of Dr. Angela Chen as Head of Business Development and Project Management.
HD Biosciences Announces Completion of Series A Financing. The current round was co-led by Morningside Venture, a private investment group founded by Hong Kong's Chan family, and Lilly Asian Ventures, the Asian venture arm of Eli Lilly & Co. And Pfizer Venture Investments, the venture arm of Pfizer Inc, also participated in this round.
HD Biosciences Announces the Appointment of VP of HTS Screening. July 7, 2008 -- HD Biosciences Inc. (HDB) announces the hiring of Dr. Shaoming Huang as Vice President, High Throughput Screening (HTS).
HD Biosciences, Sundia, and European Company NovaSecta Join CRO Service Alliance for Drug Discovery Solutions.
----------------------
----------------------
HD Biosciences (China) Co.,Ltd
590 Ruiqing Road
Zhangjiang East Campus, Pudong, Shanghai 201201,
P.R.China
Tel: (+86) 21-51163700
Fax: (+86) 21-51163766
operation@hdbiosciences.com